[go: up one dir, main page]

DK3662925T3 - Sammensætning, der omfatter fsh, til behandling af infertilitet - Google Patents

Sammensætning, der omfatter fsh, til behandling af infertilitet Download PDF

Info

Publication number
DK3662925T3
DK3662925T3 DK20150379.4T DK20150379T DK3662925T3 DK 3662925 T3 DK3662925 T3 DK 3662925T3 DK 20150379 T DK20150379 T DK 20150379T DK 3662925 T3 DK3662925 T3 DK 3662925T3
Authority
DK
Denmark
Prior art keywords
infertility
treatment
composition including
including fsh
fsh
Prior art date
Application number
DK20150379.4T
Other languages
English (en)
Inventor
Saez Joan-Carles Arce
Lisbeth Helmgaard
Bjarke Mirner Klein
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK3662925T3 publication Critical patent/DK3662925T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK20150379.4T 2015-04-17 2016-04-15 Sammensætning, der omfatter fsh, til behandling af infertilitet DK3662925T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15164043 2015-04-17
EP16719315.0A EP3283097B1 (en) 2015-04-17 2016-04-15 Fsh for treatment of infertility

Publications (1)

Publication Number Publication Date
DK3662925T3 true DK3662925T3 (da) 2021-06-28

Family

ID=52997893

Family Applications (2)

Application Number Title Priority Date Filing Date
DK20150379.4T DK3662925T3 (da) 2015-04-17 2016-04-15 Sammensætning, der omfatter fsh, til behandling af infertilitet
DK16719315.0T DK3283097T3 (da) 2015-04-17 2016-04-15 Fsh til behandling af infertilitet

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK16719315.0T DK3283097T3 (da) 2015-04-17 2016-04-15 Fsh til behandling af infertilitet

Country Status (17)

Country Link
US (3) US10660938B2 (da)
EP (2) EP3283097B1 (da)
JP (2) JP7079094B2 (da)
KR (2) KR20170137041A (da)
CN (1) CN107405385A (da)
AU (1) AU2016247498B2 (da)
CA (1) CA2975444A1 (da)
DK (2) DK3662925T3 (da)
ES (2) ES2879838T3 (da)
HU (2) HUE048757T2 (da)
MA (1) MA46548B1 (da)
MX (1) MX2017010883A (da)
PL (2) PL3283097T3 (da)
PT (2) PT3662925T (da)
RU (1) RU2704252C2 (da)
SI (2) SI3283097T1 (da)
WO (1) WO2016166288A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018500934A (ja) * 2014-12-22 2018-01-18 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Cmp依存性シアリダーゼ活性
ES2879838T3 (es) 2015-04-17 2021-11-23 Ferring Bv Composición que comprende FSH para el tratamiento de la esterilidad
ES2989511T3 (es) * 2017-09-01 2024-11-26 Ferring Bv Composición para la estimulación ovárica controlada
EP4534145A3 (en) * 2018-04-30 2025-07-02 Ferring B.V. Composition for controlled ovarian stimulation
WO2019246404A1 (en) 2018-06-22 2019-12-26 Cugene Inc. Interleukin-2 variants and methods of uses thereof
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
TW202237173A (zh) * 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
EP4504236A1 (en) * 2022-04-01 2025-02-12 Ferring B.V. Mixed protocol for treatment of infertility

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228973B (de) * 1961-05-13 1966-11-17 Skf Kugellagerfabriken Gmbh Streckwerk fuer Spinnereimaschinen
US8173592B1 (en) * 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
JO3092B1 (ar) * 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
ES2879838T3 (es) 2015-04-17 2021-11-23 Ferring Bv Composición que comprende FSH para el tratamiento de la esterilidad

Also Published As

Publication number Publication date
CA2975444A1 (en) 2016-10-20
JP2021020915A (ja) 2021-02-18
MA46548B1 (fr) 2020-03-31
PL3662925T3 (pl) 2021-10-25
JP7161511B2 (ja) 2022-10-26
AU2016247498A1 (en) 2017-08-17
EP3283097B1 (en) 2020-02-12
US11439686B2 (en) 2022-09-13
KR20170137041A (ko) 2017-12-12
PT3662925T (pt) 2021-07-01
RU2704252C2 (ru) 2019-10-25
SI3283097T1 (sl) 2020-06-30
PL3283097T3 (pl) 2020-10-19
MA46548A (fr) 2018-02-21
RU2017128296A3 (da) 2019-06-25
HUE048757T2 (hu) 2020-08-28
JP2018513161A (ja) 2018-05-24
EP3283097A1 (en) 2018-02-21
PT3283097T (pt) 2020-04-06
ES2784625T3 (es) 2020-09-29
DK3283097T3 (da) 2020-04-20
EP3662925A1 (en) 2020-06-10
MX2017010883A (es) 2017-12-07
AU2016247498B2 (en) 2021-06-03
JP7079094B2 (ja) 2022-06-01
EP3662925B1 (en) 2021-04-07
KR20240073153A (ko) 2024-05-24
RU2017128296A (ru) 2019-05-17
ES2879838T3 (es) 2021-11-23
US20180125942A1 (en) 2018-05-10
CN107405385A (zh) 2017-11-28
SI3662925T1 (sl) 2021-08-31
US20230139407A1 (en) 2023-05-04
WO2016166288A1 (en) 2016-10-20
US10660938B2 (en) 2020-05-26
HUE054300T2 (hu) 2021-08-30
US20200353053A1 (en) 2020-11-12

Similar Documents

Publication Publication Date Title
DK3286311T3 (da) Fremgangsmåde til behandling af maligniteter
DK3322722T3 (da) Midler, anvendelser og fremgangsmåder til behandling af synukleinopati
DK3072835T3 (da) Fremgangsmåde til fremføring
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3256853T3 (da) Forudsigelse af t-celleepitoper, der er egnede til vaccination
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3580211T3 (da) 2-heteroaryl-3-oxo-2,3-dihydropyridazin-4-carboxamider til behandling af cancer
DK3466432T3 (da) Fremgangsmåder til behandling af pulmonale non-tuberkuløse mykobakterielle infektioner
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3294700T3 (da) Fremgangsmåde til fremstilling af limonen-4-ol
HUE054784T2 (hu) 5-klór-2-difluor-metoxifenil-pirazolopirimidin vegyületek, amelyek JAK-gátlók
DK3204386T3 (da) Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed
DK3524255T3 (da) Sammensætning til behandling af acne
DK3374359T3 (da) Dihydroimidazopyrazinonderivater, der er nyttige ved behandling af cancer
DK3662925T3 (da) Sammensætning, der omfatter fsh, til behandling af infertilitet
DK3265087T3 (da) Fremgangsmåde til behandling med tradipitant
DK3359522T3 (da) Proces til fremstilling af N-Boc-bifenylalaninol
DK3393468T3 (da) Fremgangsmåder til behandling af en immundefektsygdom
DK3261661T3 (da) Menotropin til behandling af infertilitet
DK3529233T3 (da) Fremgangsmåde til fremstilling af 3-alkylsulfanyl-2-chlor-n-(1-alkyl-1h-tetrazol-5-yl)-4-trifluoromethyl-benzamider
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3390407T3 (da) Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
DK3262023T3 (da) Fremgangsmåde til fremstillingen af diener
DK3302573T3 (da) Sammensætning til behandlingen af hjernelæsioner
LT3347360T (lt) Junginiai, naudingi ror-gama-t slopinimui